Nordic Pharma-backed Amring Pharmaceuticals completed the acquisition of Visant Medical.

Nordic Pharma-backed Amring Pharmaceuticals, a privately held pharmaceutical company providing niche generics and value-driven brands, completed the acquisition of Visant Medical, a clinical-stage medical device company and Lacrifill® developer. Financial terms were not disclosed. “Visant is thrilled to be joining the Nordic Pharma group. Our team has been passionate about bringing a truly innovative solution to patients suffering from DED and we are excited to be joining the Nordic Pharma team as we begin our commercialization efforts,” Vartan Ghazarossian, Ph.D., Visant co-founder and CEO